Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Angel

Showing results (201-210 of 213) with videos related to

Pageof 22
Sort By:
AIDS (London, England)|April 15, 1999
Ritonavir and saquinavir combination therapy for the treatment of HIV infectionD W Cameron, A J Japour, Y Xu, et al.
Plos One|December 10, 2009
Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional studyMona R Loutfy, Trevor A Hart, Saira S Mohammed, et al.
Viruses|February 28, 2023
SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)Yulia Alexandrova, Alexis Yero, Ralph-Sydney Mboumba Bouassa, et al.
BMJ Open|December 17, 2021
CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort studyCecilia T Costiniuk, Joel Singer, Marc-André Langlois, et al.
Antiviral Therapy|November 21, 2007
External quality assessment of HLA-B*5701 reporting: an international multicentre surveyEmma Hammond, Coral-Ann Almeida, Cyril Mamotte, et al.
Cell Reports|September 7, 2023
Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ARTCaroline Dufour, Maria Julia Ruiz, Amélie Pagliuzza, et al.
AIDS Research and Human Retroviruses|July 2, 2022
Willingness of Older Canadians with HIV to Participate in HIV Cure Research Near and After the End of Life: A Mixed-Method StudyDavid Lessard, Karine Dubé, Martin Bilodeau, et al.
Lancet (London, England)|July 29, 2017
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trialDavid A Margolis, Juan Gonzalez-Garcia, Hans-Jürgen Stellbrink, et al.
Vaccines|May 25, 2024
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 StudyCecilia T Costiniuk, Terry Lee, Joel Singer, et al.
AIDS (London, England)|December 8, 2022
COVID-19 vaccine immunogenicity in people with HIVCecilia T Costiniuk, Joel Singer, Terry Lee, et al.
Pageof 22

Showing results (201-210 of 213) with videos related to

Sort By:
Pageof 22
AIDS (London, England)|April 15, 1999
Ritonavir and saquinavir combination therapy for the treatment of HIV infectionD W Cameron, A J Japour, Y Xu, et al.
Plos One|December 10, 2009
Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional studyMona R Loutfy, Trevor A Hart, Saira S Mohammed, et al.
Viruses|February 28, 2023
SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)Yulia Alexandrova, Alexis Yero, Ralph-Sydney Mboumba Bouassa, et al.
BMJ Open|December 17, 2021
CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort studyCecilia T Costiniuk, Joel Singer, Marc-André Langlois, et al.
Antiviral Therapy|November 21, 2007
External quality assessment of HLA-B*5701 reporting: an international multicentre surveyEmma Hammond, Coral-Ann Almeida, Cyril Mamotte, et al.
Cell Reports|September 7, 2023
Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ARTCaroline Dufour, Maria Julia Ruiz, Amélie Pagliuzza, et al.
AIDS Research and Human Retroviruses|July 2, 2022
Willingness of Older Canadians with HIV to Participate in HIV Cure Research Near and After the End of Life: A Mixed-Method StudyDavid Lessard, Karine Dubé, Martin Bilodeau, et al.
Lancet (London, England)|July 29, 2017
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trialDavid A Margolis, Juan Gonzalez-Garcia, Hans-Jürgen Stellbrink, et al.
Vaccines|May 25, 2024
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 StudyCecilia T Costiniuk, Terry Lee, Joel Singer, et al.
AIDS (London, England)|December 8, 2022
COVID-19 vaccine immunogenicity in people with HIVCecilia T Costiniuk, Joel Singer, Terry Lee, et al.
Pageof 22